DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Muhammad A, Coopmans EC, Delhanty PJD. et al.
Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study.
Eur J Endocrinol 2018; 269-277
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.